Watson Pharmaceuticals to divest Arizona facility

By Elaine Rigoli

Tampa, Fla., March 30 - Watson Pharmaceuticals, Inc. said it plans to establish contract-manufacturing agreements for key products with third-party suppliers or with a new owner of its Phoenix facility, but if a suitable purchaser is not identified, Watson expects to close the facility by the end of the second quarter in 2007.

The company currently manufactures 15 products at the Phoenix facility, including several manufactured for third parties, according to a news release.

The Phoenix facility is the only sterile injectable manufacturing operation owned by Watson. It was acquired in 2000 as part of the company's acquisition of Schein Pharmaceutical, Inc. and employs 236 employees.

Corona, Calif.-based Watson is a specialty pharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.